ÀÖÌìÌÃfun88(ÖйúÇø)¹Ù·½ÍøÕ¾

Quarterly report pursuant to Section 13 or 15(d)

NET INCOME PER SHARE

v3.7.0.1
NET INCOME PER SHARE
3 Months Ended
Mar. 31, 2017
NET INCOME PER SHARE Ìý
NET INCOME PER SHARE

17. NET INCOME PER SHARE

Ìý

Basic income per share excludes dilution and is computed by dividing net income attributable to ÀÖÌìÌÃfun88(ÖйúÇø)¹Ù·½ÍøÕ¾ Corporation common stockholders by the weighted average number of shares outstanding during the period. Diluted income per share reflects all potential dilutive common shares outstanding during the period and is computed by dividing net income available to ÀÖÌìÌÃfun88(ÖйúÇø)¹Ù·½ÍøÕ¾ Corporation common stockholders by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding as dilutive securities.

Ìý

Basic and diluted income per share is determined using the following information (in millions):

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

ThreeÌýmonths

Ìý

Ìý

ended

Ìý

Ìý

MarchÌý31,Ìý

Ìý

ÌýÌýÌýÌý

2017

ÌýÌýÌýÌý

2016

Numerator:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Basic and diluted income from continuing operations:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Income from continuing operations attributable to ÀÖÌìÌÃfun88(ÖйúÇø)¹Ù·½ÍøÕ¾ Corporation

Ìý

$

77

Ìý

$

57

Basic and diluted net income:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Net income attributable to ÀÖÌìÌÃfun88(ÖйúÇø)¹Ù·½ÍøÕ¾ Corporation

Ìý

$

76

Ìý

$

56

Denominator:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Weighted average shares outstanding

Ìý

Ìý

237.4

Ìý

Ìý

236.1

Dilutive shares:

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Stock-based awards

Ìý

Ìý

5.1

Ìý

Ìý

1.8

Total weighted average shares outstanding, including dilutive shares

Ìý

Ìý

242.5

Ìý

Ìý

237.9

Ìý

Additional stock‑based awards of 2.2 million and 11.8Ìýmillion weighted average equivalent shares of stock were outstanding during the three months ended March 31, 2017 and 2016, respectively. However, these stock‑based awards were not included in the computation of diluted earnings per share for the three months ended March 31, 2017 and 2016 because the effect would be anti‑dilutive.